John T. Poirier

16.6k total citations · 7 hit papers
86 papers, 6.9k citations indexed

About

John T. Poirier is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John T. Poirier has authored 86 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 35 papers in Molecular Biology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John T. Poirier's work include Lung Cancer Research Studies (30 papers), Neuroendocrine Tumor Research Advances (14 papers) and Virus-based gene therapy research (9 papers). John T. Poirier is often cited by papers focused on Lung Cancer Research Studies (30 papers), Neuroendocrine Tumor Research Advances (14 papers) and Virus-based gene therapy research (9 papers). John T. Poirier collaborates with scholars based in United States, Germany and Canada. John T. Poirier's co-authors include Charles M. Rudin, Elisa de Stanchina, Benjamin H. Lok, Eric E. Gardner, Natasha Rekhtman, J. Laird, Joshua K. Sabari, Afshin Dowlati, Pierre P. Massion and Christine L. Hann and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

John T. Poirier

83 papers receiving 6.8k citations

Hit Papers

Molecular subtypes of sma... 2001 2026 2009 2017 2019 2001 2016 2020 2020 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
    2019 718 citations Charles M. Rudin, John T. Poirier et al. profile →
  2. Prediction of cognitive decline in normal elderly subjects with 2-[ 18 F]fluoro-2-deoxy- d -glucose/positron-emission tomography (FDG/PET)
    2001 522 citations John T. Poirier et al. profile →
  3. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets
    2016 325 citations Natasha Rekhtman, M. Catherine Pietanza et al. Clinical Cancer Research profile →
  4. SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
    2020 301 citations William D. Travis, Triparna Sen et al. profile →
  5. Regenerative lineages and immune-mediated pruning in lung cancer metastasis
    2020 251 citations Ashley M. Laughney, Jing Hu et al. Nature Medicine profile →
  6. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
    2020 243 citations Francisco J. Sánchez‐Rivera, Scott W. Lowe et al. profile →
  7. TMEM41B Is a Pan-flavivirus Host Factor
    2020 136 citations Linde A. Miles, Charles M. Rudin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John T. Poirier United States 40 3.5k 3.1k 1.9k 1.1k 754 86 6.9k
Kazuo Nagashima Japan 50 2.4k 0.7× 3.3k 1.1× 704 0.4× 828 0.8× 496 0.7× 300 9.0k
Stefan Müller Germany 52 2.6k 0.7× 5.9k 1.9× 1.5k 0.8× 898 0.8× 801 1.1× 157 10.9k
Charles Cobbs United States 42 1.8k 0.5× 1.5k 0.5× 2.6k 1.3× 1.5k 1.4× 633 0.8× 88 6.4k
Robin J. Leach United States 47 1.5k 0.4× 4.8k 1.6× 548 0.3× 1.6k 1.4× 791 1.0× 248 9.3k
Pedro R. Löwenstein United States 58 2.2k 0.6× 5.4k 1.7× 905 0.5× 429 0.4× 802 1.1× 304 11.1k
Burt Nabors United States 52 2.3k 0.6× 4.2k 1.4× 981 0.5× 1.3k 1.2× 2.0k 2.6× 267 9.5k
Florence M. Hofman United States 56 1.4k 0.4× 2.9k 0.9× 2.0k 1.0× 462 0.4× 728 1.0× 172 9.6k
Andrea Varró United Kingdom 53 2.3k 0.6× 3.4k 1.1× 1.2k 0.6× 1.2k 1.1× 879 1.2× 204 9.8k
Andrew W. Bollen United States 51 885 0.2× 3.1k 1.0× 1.0k 0.5× 1.2k 1.1× 826 1.1× 141 8.8k
Andrew V. Kossenkov United States 49 2.1k 0.6× 5.5k 1.8× 758 0.4× 619 0.6× 1.8k 2.4× 181 8.5k

Countries citing papers authored by John T. Poirier

Since Specialization
Citations

This map shows the geographic impact of John T. Poirier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John T. Poirier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John T. Poirier more than expected).

Fields of papers citing papers by John T. Poirier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John T. Poirier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John T. Poirier. The network helps show where John T. Poirier may publish in the future.

Co-authorship network of co-authors of John T. Poirier

This figure shows the co-authorship network connecting the top 25 collaborators of John T. Poirier. A scholar is included among the top collaborators of John T. Poirier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John T. Poirier. John T. Poirier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoang, Tran, David Bauer, Lukas M. Carter, et al.. (2023). A theranostic approach: Imaging and therapy of delta-like ligand 3–expressing small cell lung cancers.. Journal of Clinical Oncology. 41(16_suppl). 8575–8575.
2.
Poirier, John T., et al.. (2022). Generation of hepatoma cell lines deficient in microsomal triglyceride transfer protein. Journal of Lipid Research. 63(9). 100257–100257. 9 indexed citations
3.
Wohlhieter, Corrin A., Fathema Uddin, Àlvaro Quintanal-Villalonga, et al.. (2021). An optimized NGS sample preparation protocol for in vitro CRISPR screens. STAR Protocols. 2(2). 100390–100390. 2 indexed citations
4.
Sharma, Sai Kiran, Pierre Adumeau, Outi Keinänen, et al.. (2021). Synthesis and Comparative In Vivo Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPET. Bioconjugate Chemistry. 32(7). 1255–1262. 12 indexed citations
5.
Laughney, Ashley M., Jing Hu, Nathaniel R. Campbell, et al.. (2020). Regenerative lineages and immune-mediated pruning in lung cancer metastasis. Nature Medicine. 26(2). 259–269. 251 indexed citations breakdown →
6.
Laddha, Saurabh V., Edaise M. da Silva, Kenneth Robzyk, et al.. (2019). Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids. Cancer Research. 79(17). 4339–4347. 50 indexed citations
7.
Devarakonda, Siddhartha, Sumithra Sankararaman, Brett H. Herzog, et al.. (2019). Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations. Clinical Cancer Research. 25(20). 6119–6126. 41 indexed citations
8.
Sharma, Sai Kiran, Serge K. Lyashchenko, Nagavarakishore Pillarsetty, et al.. (2019). A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals. Nuclear Medicine and Biology. 71. 32–38. 37 indexed citations
9.
Sharma, Sai Kiran, Andrew Chow, Sébastien Monette, et al.. (2018). Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models. Cancer Research. 78(7). 1820–1832. 81 indexed citations
10.
Laird, J., Benjamin H. Lok, Jennifer Ma, et al.. (2018). Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and Xenografts. Clinical Cancer Research. 24(20). 5143–5152. 55 indexed citations
11.
Ruscetti, Marcus, Josef Leibold, Matthew J. Bott, et al.. (2018). NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 362(6421). 1416–1422. 268 indexed citations
12.
Cooper, Jonathan M., Qingwen Xu, Lü Zhou, et al.. (2017). Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis. Molecular Cancer Therapeutics. 16(8). 1693–1704. 33 indexed citations
13.
Gardner, Eric E., Benjamin H. Lok, Valentina E. Schneeberger, et al.. (2017). Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis. Cancer Cell. 31(2). 286–299. 347 indexed citations
14.
Lok, Benjamin H., Eric E. Gardner, Valentina E. Schneeberger, et al.. (2016). PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer. Clinical Cancer Research. 23(2). 523–535. 261 indexed citations
15.
Rekhtman, Natasha, M. Catherine Pietanza, Matthew D. Hellmann, et al.. (2016). Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets. Clinical Cancer Research. 22(14). 3618–3629. 325 indexed citations breakdown →
16.
Rudin, Charles M. & John T. Poirier. (2016). Shining light on novel targets and therapies. Nature Reviews Clinical Oncology. 14(2). 75–76. 53 indexed citations
17.
Gardner, Eric E., Nick Connis, John T. Poirier, et al.. (2014). Rapamycin Rescues ABT-737 Efficacy in Small Cell Lung Cancer. Cancer Research. 74(10). 2846–2856. 45 indexed citations
18.
Rudin, Charles M., John T. Poirier, Neil Senzer, et al.. (2011). Phase I Clinical Study of Seneca Valley Virus (SVV-001),a Replication-Competent Picornavirus, in Advanced Solid Tumors with Neuroendocrine Features. Clinical Cancer Research. 17(4). 888–895. 128 indexed citations
19.
Hillion, Jöelle, Lisa J. Wood, Mita Mukherjee, et al.. (2009). Upregulation of MMP-2 by HMGA1 Promotes Transformation in Undifferentiated, Large-Cell Lung Cancer. Molecular Cancer Research. 7(11). 1803–1812. 66 indexed citations
20.
Mosley, Jonathan D., John T. Poirier, Darcie D. Seachrist, Melissa D. Landis, & Ruth A. Keri. (2007). Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer. Molecular Cancer Therapeutics. 6(8). 2188–2197. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuo Nagashima Breakdown of academic impact, for papers by Stefan Müller Breakdown of academic impact, for papers by Charles Cobbs Breakdown of academic impact, for papers by Robin J. Leach Breakdown of academic impact, for papers by Pedro R. Löwenstein Breakdown of academic impact, for papers by Burt Nabors Breakdown of academic impact, for papers by Florence M. Hofman Breakdown of academic impact, for papers by Andrea Varró Breakdown of academic impact, for papers by Andrew W. Bollen Breakdown of academic impact, for papers by Andrew V. Kossenkov
Rankless by CCL
2026